Regeneron’s promising antibody for cat, birch allergies; Ascletis targets quarterly GLP-1 shotnews2025-09-09T14:51:27+00:00September 9th, 2025|Endpoints News|
Eli Lilly offers AI models to biotechs with TuneLab launchnews2025-09-09T11:00:16+00:00September 9th, 2025|Endpoints News|
Novartis to spend $1.4B on Tourmaline Bio, gaining new heart drugnews2025-09-09T10:47:20+00:00September 9th, 2025|Endpoints News|
Ridge Bio raises $25M to help drugmakers come up with better ADCsnews2025-09-09T10:00:04+00:00September 9th, 2025|Endpoints News|
Summit plays defense for the first time as questions loom over Phase 3 datanews2025-09-08T19:01:44+00:00September 8th, 2025|Endpoints News|
New FDA approval pathway for n-of-1 therapies coming soon, Prasad saysnews2025-09-08T18:57:01+00:00September 8th, 2025|Endpoints News|
Pfizer reports new Covid-19 vaccine data from open-label studynews2025-09-08T18:13:38+00:00September 8th, 2025|Endpoints News|
Eli Lilly’s Jaypirca shows ‘striking’ results in first-line lymphoma patients news2025-09-08T17:22:51+00:00September 8th, 2025|Endpoints News|
Dianthus’ selective complement inhibitor yields Phase 2 success in myasthenia gravisnews2025-09-08T15:29:39+00:00September 8th, 2025|Endpoints News|
#WCLC25: BioNTech, Bristol Myers tout PD-L1xVEGF results in small cell lung cancernews2025-09-08T15:00:45+00:00September 8th, 2025|Endpoints News|
